Boston Children's Hospital Jan 22 2026 Caring Cross, a 501(c)(3) non-profit dedicated to improving access to advanced therapies, and Boston Children's Hospital today announced a collaboration to provide a sustainable, affordable pathway for patients to access stem cell gene therapies for the treatment of Sickle Cell Disease (SCD). The partnership centers on a worldwide license granted to Caring Cross by Boston Children's for lentiviral-based BCL11A-LCRshRNAmiR, an innovative technology designed